TOP1 and breast carcinoma: To test this, we performed Cleavage Under Targets and Release Using Nuclease (CUT&RUN) followed by next-generation sequencing (NGS) for macroH2A1.1 and TOP1 in MDA-MB-231 breast cancer cells, which express relatively high levels of macroH2A1.124.